Targeted Drug Delivery Strategies for Infectious Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 44
Special Issue Editors
Interests: nanotechnology; oxidative stress; chemotherapy of trypanosomatids; photoprotection
Special Issues, Collections and Topics in MDPI journals
Interests: anti-inflammatory effects; leishmaniasis; infectious diseases; treatment; prognosis; diagnosis; drug delivery; ecofriendly nanogel
Interests: leishmaniasis; clinical immunology; infectious diseases; antimicrobial; photodynamic therapy; chemotherapy
Special Issue Information
Dear Colleagues,
Infectious diseases that can be transmitted, either directly or indirectly, from one person to another through pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi, are long-standing threats to human society. These diseases lead to high mortality rates, disrupt health systems, and negatively impact the economy, particularly in middle- and low-income countries. The emergence of new diseases, such as COVID-19 in 2020, the rise in antimicrobial resistance, and the persistence of longstanding diseases like leishmaniasis, tuberculosis, and Chagas disease present formidable challenges and demand effective public health strategies. The development of new treatment options is essential, focusing on therapies that are highly effective, less toxic, and affordable. In this context, a promising approach is the development of drug-specific delivery systems that target the desired site of action, utilizing recent advances in biomaterials, including liposomes, dendrimers, nanotubes, nanoshells, and others.
This Special Issue will provide readers with an overview of the current advances in targeted drug delivery strategies for infectious diseases. Research articles and comprehensive reviews are welcome.
Dr. Danielle Lazarin Bidóia
Dr. Daniele Stéfanie Sara Lopes Lera-Nonose
Dr. Áquila Carolina Fernandes Herculano Ramos Milaré
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious disease
- treatment
- delivery system
- biomaterial
- targeted drug therapy
- liposome
- dendrimer
- nanotube
- nanotechnology
- formulation
- polymer
- antifungal
- antimicrobial
- antiparasitic
- antibiotic
- bacterial infection
- adjuvant
- antiviral
- biofilm-related infection
- bacteria
- antiparasitic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
